1. Home
  2. FCFS vs KYMR Comparison

FCFS vs KYMR Comparison

Compare FCFS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstCash Holdings Inc.

FCFS

FirstCash Holdings Inc.

HOLD

Current Price

$212.90

Market Cap

9.7B

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$114.82

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCFS
KYMR
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
FCFS
KYMR
Price
$212.90
$114.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
26
Target Price
$210.67
$107.72
AVG Volume (30 Days)
417.2K
1.2M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
0.78%
N/A
EPS Growth
29.49
N/A
EPS
2.43
N/A
Revenue
$3,661,043,000.00
$39,211,000.00
Revenue This Year
$16.20
$10.61
Revenue Next Year
$8.35
$8.17
P/E Ratio
$88.54
N/A
Revenue Growth
8.04
N/A
52 Week Low
$119.21
$36.88
52 Week High
$235.97
$130.05

Technical Indicators

Market Signals
Indicator
FCFS
KYMR
Relative Strength Index (RSI) 45.08 62.29
Support Level $206.05 $76.40
Resistance Level $231.35 $120.90
Average True Range (ATR) 7.79 5.87
MACD -0.59 -0.87
Stochastic Oscillator 38.77 62.96

Price Performance

Historical Comparison
FCFS
KYMR

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: